- 関
- EF-2
WordNet
- be a contributing factor; "make things factor into a companys profitability"
- any of the numbers (or symbols) that form a product when multiplied together
- an independent variable in statistics
- anything that contributes causally to a result; "a number of factors determined the outcome"
- consider as relevant when making a decision; "You must factor in the recent developments" (同)factor in, factor out
- resolve into factors; "a quantum computer can factor the number 15" (同)factor in, factor out
- an event known to have happened or something known to have existed; "your fears have no basis in fact"; "how much of the story is fact and how much fiction is hard to tell"
- a concept whose truth can be proved; "scientific hypotheses are not facts"
- a piece of information about circumstances that exist or events that have occurred; "first you must collect all the facts of the case"
- a statement or assertion of verified information about something that is the case or has happened; "he supported his argument with an impressive array of facts"
- an addition to the length of something (同)extension
- the act of lengthening something
- the quality of being elongated
- amide combining the amino group of one amino acid with the carboxyl group of another; usually obtained by partial hydrolysis of protein
PrepTutorEJDIC
- (…の)『要因』,(…を生み出す)要素《+『in』+『名』(do『ing』)》 / 囲数,約数 / 代理人,《おもに英》仲買人 / =factorize
- 〈C〉『事実』,実際にある(あった)事 / 〈U〉真相,真実(truth) / 《the~》(法律用語で)犯行
- 〈U〉伸長,延長 / 〈C〉伸長部,延長部
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/10/19 04:29:43」(JST)
wiki en
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. プロトロンビンG20210A変異 prothrombin g20210a mutation
- 2. 肝臓の合成能の検査（アルブミン、凝固因子、プロトロンビン時間など） tests of the livers biosynthetic capacity eg albumin coagulation factors prothrombin time
- 3. 出血症状を有する小児に対するアプローチ approach to the child with bleeding symptoms
- 4. 出血性素因を有する成人患者へのアプローチ approach to the adult patient with a bleeding diathesis
- 5. 関節リウマチの診断および評価における生物学的マーカー biologic markers in the diagnosis and assessment of rheumatoid arthritis
English Journal
- Enhanced anti-colon cancer immune responses with modified eEF2-derived peptides.
- Sun W1, Wei X2, Niu A3, Ma X4, Li JJ5, Gao D2.
- Cancer letters.Cancer Lett.2015 Dec 1;369(1):112-23. doi: 10.1016/j.canlet.2015.08.002. Epub 2015 Aug 21.
- Eukaryotic elongation factor-2 (eEF2) is overexpressed in many human cancers and is an attractive target for cancer immunotherapy. The eEF2 derived polypeptides have been shown to be able to induce cytotoxic T lymphocytes from healthy donor. Here, we demonstrate the evidence indicating that modifica
- PMID 26304717
- Phosphatase control of 4E-BP1 phosphorylation state is central for glycolytic regulation of retinal protein synthesis.
- Gardner TW1, Abcouwer SF2, Losiewicz MK2, Fort PE3.
- American journal of physiology. Endocrinology and metabolism.Am J Physiol Endocrinol Metab.2015 Sep 15;309(6):E546-56. doi: 10.1152/ajpendo.00180.2015. Epub 2015 Jul 21.
- Control of protein synthesis in insulin-responsive tissues has been well characterized, but relatively little is known about how this process is regulated in nervous tissues. The retina exhibits a relatively high protein synthesis rate, coinciding with high basal Akt and metabolic activities, with t
- PMID 26199279
- Loss of diphthamide pre-activates NF-κB and death receptor pathways and renders MCF7 cells hypersensitive to tumor necrosis factor.
- Stahl S1, da Silva Mateus Seidl AR2, Ducret A3, Kux van Geijtenbeek S3, Michel S3, Racek T4, Birzele F4, Haas AK1, Rueger R4, Gerg M5, Niederfellner G2, Pastan I6, Brinkmann U7.
- Proceedings of the National Academy of Sciences of the United States of America.Proc Natl Acad Sci U S A.2015 Aug 25;112(34):10732-7. doi: 10.1073/pnas.1512863112. Epub 2015 Aug 10.
- The diphthamide on human eukaryotic translation elongation factor 2 (eEF2) is the target of ADP ribosylating diphtheria toxin (DT) and Pseudomonas exotoxin A (PE). This modification is synthesized by seven dipthamide biosynthesis proteins (DPH1-DPH7) and is conserved among eukaryotes and archaea. We
- PMID 26261303
Japanese Journal
- Eukaryotic Elongation Factor 1A2 (eEF1A2) Participates in the Expression of Antiadhesive Effect of FNIII14, a Peptide Derived from Fibronectin
- AKASHI Takuya,KOJIMA Chihiro,IYODA Takuya,FUKAI Fumio
- Peptide
- NAID 10030204401
- Eukaryotic Translation Elongation Factor (eEF1A) Serves as a Membrane Receptor Mediating Anti-Adhesive Effect of Peptide FNIII14
- IYODA Takuya,ITO Nao,MATSUZAWA Rie,ITAGAKI Keisuke,NAITO Toshihiko,FUKAI Fumio
- Peptide
- NAID 10030204047
- フィブロネクチン分子由来インテグリン機能抑制性ペプチドの相互作用部位の予測
- 近藤 洋介,權 娟大,宮崎 智
- 研究報告バイオ情報学（BIO） 2011-BIO-27(12), 1-6, 2011-11-24
- … を構築するタンパク質であるが，フィブロネクチンの 22-mer のフラグメント FNIII14 は足場への接着を媒介する分子インテグリンの機能を抑制する．最近，タンパク質翻訳伸長因子 eEF1A（Eukaryotic Elongation Factor 1A） が FNIII14 の細胞膜受容体であることが示唆された．eEF1A は細胞質でペプチド鎖伸長に関わる因子であり，細胞膜上での機能はあまり知られていない．細胞膜上での eEF1A の機能を解明すれば …
- NAID 110008694774
Related Links
- Peptide Elongation Factor 2; Cytoplasmic Elongation Factor 2; Elongation Factor 2; EF-2. On-line free medical diagnosis assistant. Ranked list of possible diseases from either several symptoms or a full patient history. A similarity ...
- Peptide Elongation Factor 2 information including symptoms, causes, diseases, symptoms, treatments, and other medical and health issues. ... Introduction: Peptide Elongation Factor 2 Description of Peptide Elongation Factor 2 ...
Related Pictures
★リンクテーブル★
| リンク元 | 「伸長因子2」「ペプチド伸長因子2」 |
| 関連記事 | 「elongation」「fact」「factor」 |
「伸長因子2」
「ペプチド伸長因子2」
「elongation」
- n.
「fact」
- n.
「factor」
- n.